Retatrutide

Retatrutide / GLP-3 (10 mg) – Research Peptide

Retatrutide / GLP-3 is a novel synthetic peptide and triple agonist that simultaneously targets GLP-1 (Glucagon-like Peptide-1), GIP (Glucose-dependent Insulinotropic Polypeptide), and Glucagon receptors. It is currently one of the most studied next-generation compounds in metabolic and obesity research.

Key Research Applications:

Investigation of multi-receptor agonism for weight management
Studies on fat metabolism and energy expenditure
Research into improved glycemic control and insulin sensitivity
Exploration of appetite regulation and satiety mechanisms
Comparative studies against dual agonists (e.g., Tirzepatide)

In laboratory research, Retatrutide / GLP-3 has demonstrated powerful effects on reducing body weight, improving lipid profiles, and enhancing metabolic function through its unique triple-action mechanism. Unlike single or dual agonists, the addition of glucagon receptor activity may support greater increases in energy expenditure while maintaining excellent glycemic control.

Technical Specifications:

Purity: ≥99% (HPLC verified)
Form: Lyophilized white powder
Sequence: Synthetic triple agonist peptide
Molecular Weight: Approximately 4,800 g/mol
Storage: Lyophilized form stable at -20°C. Reconstituted solution should be refrigerated and used within 30 days.

For Research Use Only (RUO)
This product is intended strictly for in vitro and in vivo laboratory research and scientific investigation. It is not for human consumption, therapeutic use, or any diagnostic purpose. Always follow proper laboratory safety protocols and local regulations when handling research peptides.

Researchers interested in metabolic disorders, obesity pharmacology, and multi-agonist peptides frequently choose Retatrutide due to its promising profile in preclinical and early clinical studies. Each vial comes with a downloadable Certificate of Analysis (COA) confirming purity and quality.

Why Choose Jartides Retatrutide?